
Edward Raymond
Examiner (ID: 19266, Phone: (571)272-2221 , Office: P/2857 )
| Most Active Art Unit | 2857 |
| Art Unit(s) | 2857 |
| Total Applications | 1533 |
| Issued Applications | 1393 |
| Pending Applications | 52 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10712733
[patent_doc_number] => 20160058880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'MINIMALLY TOXIC PRODRUGS'
[patent_app_type] => utility
[patent_app_number] => 14/758002
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29012
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758002
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/758002 | Minimally toxic prodrugs | Dec 26, 2013 | Issued |
Array
(
[id] => 10468591
[patent_doc_number] => 20150353607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Glycopeptide Compound Or Pharmaceutical Salt Thereof And Method For Preparing Same, And Pharmaceutical Compositions And Applications Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/655830
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9139
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655830
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655830 | Glycopeptide compound or pharmaceutical salt thereof and method for preparing same, and pharmaceutical compositions and applications thereof | Dec 25, 2013 | Issued |
Array
(
[id] => 10946927
[patent_doc_number] => 20140349948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Treatment of Chronic Constipation'
[patent_app_type] => utility
[patent_app_number] => 14/138237
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11117
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138237
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/138237 | Treatment of Chronic Constipation | Dec 22, 2013 | Abandoned |
Array
(
[id] => 11872495
[patent_doc_number] => 09744244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Amphipathic peptide'
[patent_app_type] => utility
[patent_app_number] => 14/649606
[patent_app_country] => US
[patent_app_date] => 2013-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 79
[patent_no_of_words] => 22338
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649606
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/649606 | Amphipathic peptide | Dec 8, 2013 | Issued |
Array
(
[id] => 11561709
[patent_doc_number] => 09624282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Microdystrophin peptides and methods for treating muscular dystrophy using the same'
[patent_app_type] => utility
[patent_app_number] => 14/091326
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 32
[patent_no_of_words] => 17381
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091326
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091326 | Microdystrophin peptides and methods for treating muscular dystrophy using the same | Nov 25, 2013 | Issued |
Array
(
[id] => 12526923
[patent_doc_number] => 10005817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Peptide pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 14/646246
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 15
[patent_no_of_words] => 61089
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646246
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646246 | Peptide pharmaceuticals | Nov 19, 2013 | Issued |
Array
(
[id] => 11633893
[patent_doc_number] => 09655848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Liposomes for in-vivo delivery'
[patent_app_type] => utility
[patent_app_number] => 14/440834
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11263
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440834 | Liposomes for in-vivo delivery | Nov 18, 2013 | Issued |
Array
(
[id] => 10412723
[patent_doc_number] => 20150297732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'BIODEGRADABLE MICROBEAD COMPRISING ANIONIC POLYMER FOR IMPROVING ADSORPTIVE POWER TO ANTICANCER DRUGS, AND METHOD FOR PREPARING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/647270
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4296
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647270
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/647270 | Biodegradable microbead comprising anionic polymer for improving adsorptive power to anticancer drugs, and method for preparing same | Nov 14, 2013 | Issued |
Array
(
[id] => 9319492
[patent_doc_number] => 20140051830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'In-Process Control for the Manufacture of Glatiramer Acetate'
[patent_app_type] => utility
[patent_app_number] => 14/065053
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5495
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14065053
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/065053 | In-Process Control for the Manufacture of Glatiramer Acetate | Oct 27, 2013 | Abandoned |
Array
(
[id] => 10975360
[patent_doc_number] => 20140378395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Peptides for the Treatment of Hearing'
[patent_app_type] => utility
[patent_app_number] => 14/047802
[patent_app_country] => US
[patent_app_date] => 2013-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 50225
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/047802 | Peptides for the Treatment of Hearing | Oct 6, 2013 | Abandoned |
Array
(
[id] => 10769043
[patent_doc_number] => 20160115199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'Cell Penetrating Peptides for Intracellular Delivery of Molecules'
[patent_app_type] => utility
[patent_app_number] => 14/433578
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6251
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433578
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433578 | Cell penetrating peptides for intracellular delivery of molecules | Oct 3, 2013 | Issued |
Array
(
[id] => 10389773
[patent_doc_number] => 20150274780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'CONFORMATIONALLY-CONSTRAINED KINKED ENDOSOMAL-DISRUPTING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/438194
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13580
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438194
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/438194 | Conformationally-constrained kinked endosomal-disrupting peptides | Oct 2, 2013 | Issued |
Array
(
[id] => 9211590
[patent_doc_number] => 20140010767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'METHODS AND MATERIALS FOR PROVIDING TEETH WITH A WHITE APPEARANCE'
[patent_app_type] => utility
[patent_app_number] => 14/029115
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9076
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/029115 | Methods and materials for providing teeth with a white appearance | Sep 16, 2013 | Issued |
Array
(
[id] => 9641943
[patent_doc_number] => 20140220054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/028329
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24737
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028329 | WT1 HLA class II—binding peptides and compositions and methods comprising same | Sep 15, 2013 | Issued |
Array
(
[id] => 10325737
[patent_doc_number] => 20150210741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/425010
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9140
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425010
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/425010 | JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT | Aug 21, 2013 | Abandoned |
Array
(
[id] => 10347505
[patent_doc_number] => 20150232511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHOD FOR PRODUCING A COMPOSITION FOR TREATING A TOOTH LESION'
[patent_app_type] => utility
[patent_app_number] => 14/421666
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9750
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421666 | Method for producing a composition for treating a tooth lesion | Aug 13, 2013 | Issued |
Array
(
[id] => 11907080
[patent_doc_number] => 09775877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Combinations with a backbone-cyclized peptide'
[patent_app_type] => utility
[patent_app_number] => 14/419986
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4909
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419986
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419986 | Combinations with a backbone-cyclized peptide | Aug 6, 2013 | Issued |
Array
(
[id] => 10339163
[patent_doc_number] => 20150224168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMBINATIONS WITH A BACKBONE-CYCLIZED PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/419992
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9176
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419992
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419992 | Combinations with a backbone-cyclized peptide | Aug 6, 2013 | Issued |
Array
(
[id] => 9162042
[patent_doc_number] => 20130310319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'FAST DISSOLVING PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/952084
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11370
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952084
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952084 | Fast dissolving pharmaceutical composition | Jul 25, 2013 | Issued |
Array
(
[id] => 10341736
[patent_doc_number] => 20150226740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'METHOD FOR IDENTIFYING NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/421310
[patent_app_country] => US
[patent_app_date] => 2013-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30173
[patent_no_of_claims] => 180
[patent_no_of_ind_claims] => 105
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421310
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/421310 | Method for identifying novel minor histocompatibility antigens | Jul 24, 2013 | Issued |